I 

117TH CONGRESS 

2D SESSION H. R. 7125 

To amend the Department of Defense Cooperative Threat Reduction Act 

to prevent the proliferation of biological weapons under the Cooperative 

Threat Reduction Program, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 17, 2022 

Mrs. GREENE of Georgia introduced the following bill; which was referred to 

the Committee on Foreign Affairs, and in addition to the Committee on 

Appropriations, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To amend the Department of Defense Cooperative Threat 

Reduction Act to prevent the proliferation of biological 

weapons under the Cooperative Threat Reduction Program, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Stopping the Spread 

5 of Taxpayer-Funded Bioweapons Act of 2022’’. 


pbinns on DSKJLVW7X2PROD with BILLS
2 

•HR 7125 IH

1 SEC. 2. PREVENTING THE PROLIFERATION OF BIOLOGICAL 

2 WEAPONS UNDER THE COOPERATIVE 

3 THREAT REDUCTION PROGRAM. 

4 (a) PREVENTION OF THE PROLIFERATION OF BIO5 LOGICAL WEAPONS.— 

6 (1) IN GENERAL.—Section 1331(a) of the De7 partment of Defense Cooperative Threat Reduction 

8 Act (50 U.S.C. 3731(a)) is amended by adding at 

9 the end the following new paragraphs: 

10 ‘‘(6) Cooperative biological engagement. 

11 ‘‘(7) Activities that facilitate the detection and 

12 reporting of highly pathogenic diseases or other dis13 eases that are associated with or that could be used 

14 as an early warning mechanism for disease out15 breaks, regardless of whether such diseases are 

16 caused by biological weapons.’’. 

17 (2) CONFORMING AMENDMENTS.—Such Act (50 

18 U.S.C. 3701 et seq.) is further amended as follows: 

19 (A) By striking ‘‘, nuclear, or biological 

20 weapons’’ each place it appears and inserting 

21 ‘‘or nuclear weapons’’. 

22 (B) In section 1321— 

23 (i) in subsection (a)— 

24 (I) in paragraph (1), by striking 

25 ‘‘, biological,’’; 


pbinns on DSKJLVW7X2PROD with BILLS
3 

•HR 7125 IH

1 (II) by striking paragraph (4); 

2 and 

3 (III) by redesignating paragraphs 

4 (5) and (6) as paragraphs (4) and 

5 (5), respectively; and 

6 (ii) in paragraph (4), as so redesig7 nated, by striking ‘‘, chemical, and biologi8 cal’’ and inserting ‘‘and chemical’’. 

9 (C) In section 1344, by striking ‘‘, nuclear, 

10 and biological weapons’’ and inserting ‘‘and nu11 clear weapons’’. 

12 (b) PROHIBITION ON AVAILABILITY OF FUNDS.— 

13 (1) PROHIBITION ON AVAILABILITY OF

14 FUNDS.—Notwithstanding section 1681(a)(4) of the 

15 National Defense Authorization Act for Fiscal Year 

16 2022 (Public Law 117–81), none of the funds au17 thorized to be appropriated for the Cooperative 

18 Threat Reduction program under the Department of 

19 Defense Cooperative Threat Reduction Act (50 

20 U.S.C. 3701 et seq.) for fiscal year 2022 or any fis21 cal year thereafter may be obligated or expended for 

22 cooperative biological engagement. 

23 (2) RESCISSION OF FUNDS.—Any unobligated 

24 funds available for the Cooperative Threat Reduc25 tion program for cooperative biological engagement 


pbinns on DSKJLVW7X2PROD with BILLS
4 

•HR 7125 IH

1 as of the date of the enactment of this Act are here2 by rescinded and deposited into the general fund of 

3 the Treasury. 

Æ 


pbinns on DSKJLVW7X2PROD with BILLS